Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ICV is a private chemicals company operating under the ICV Global brand that develops, co-produces, and distributes specialty chemical products for multiple end markets, including pharmaceutical and cosmeceutical applications. In healthcare-related markets, the company primarily supplies pharmaceutical excipients, inactive ingredients, and formulation-support materials rather than developing therapeutic drugs. Its product portfolio includes materials such as pharmaceutical-grade lactose, povidones, and pyrogenic fumed silica marketed under the Metoxsil brand. The company appears to operate internationally with headquarters in Hamburg, Germany and additional offices in Ras Al Khaimah, UAE, and Shanghai, China. Overall, ICV is best characterized as a commercial specialty chemicals and pharma ingredients supplier serving downstream manufacturers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ICV.